These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder. Chadwick D; Hallett M; Jenner P; Marsden CD Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645 [No Abstract] [Full Text] [Related]
4. Beneficial effects of serotonin precursors in postanoxic action myoclonus. De Léan J; Richardson JC; Hornykiewicz O Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968 [TBL] [Abstract][Full Text] [Related]
5. Post-hypoxic intention myoclonus treated with 5-hydroxy-tryptophan and an extracerebral decarboxylase inhibitor. Magnussen I; Dupont E; Engbaek F; de Fine Olivarius B Acta Neurol Scand; 1978 Apr; 57(4):289-94. PubMed ID: 307327 [TBL] [Abstract][Full Text] [Related]
10. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Van Woert MH; Sethy VH Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720 [TBL] [Abstract][Full Text] [Related]
11. Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. Hallett M; Chadwick D; Adam J; Marsden CD J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):253-64. PubMed ID: 301926 [TBL] [Abstract][Full Text] [Related]
12. Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. Beretta E; Regli F; de Crousaz G; Steck AJ J Neurol; 1981; 225(1):57-62. PubMed ID: 6164757 [TBL] [Abstract][Full Text] [Related]
13. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. Van Woert MH; Rosenbaum D; Howieson J; Bowers MB N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan. Gascon G; Wallenberg B; Daif AK; Ozand P Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864 [TBL] [Abstract][Full Text] [Related]
15. Pathological findings in a case of hypoxic myoclonus treated with 5-hydroxytryptophan and a decarboxylase inhibitor. De Léan J; Richardson JC; Rewcastle NB Adv Neurol; 1986; 43():215-23. PubMed ID: 2418647 [TBL] [Abstract][Full Text] [Related]
17. Letter: Relief of action myoclonus by 5-hydroxytryptophan. Chadwick D; Reynolds EH; Marsden CD Lancet; 1974 Jul; 2(7872):111-2. PubMed ID: 4136988 [No Abstract] [Full Text] [Related]
18. Improvement of action myoclonus by an administration of 5-hydroxytryptophan and carbidopa in a child with muscular subsarcolemmal hyperactivity. Nakano K; Hayakawa T; Shishikura K; Ohsawa M; Suzuki H; Fukuyama Y Brain Dev; 1990; 12(5):516-20. PubMed ID: 2288384 [TBL] [Abstract][Full Text] [Related]
19. Myoclonus. Marsden CD Mod Trends Neurol; 1975; 6():321-2. PubMed ID: 1105145 [No Abstract] [Full Text] [Related]
20. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Growdon JH; Young RR; Shahani BT Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]